Baran, W.; Krzemińska, J.; Szlagor, M.; Wronka, M.; Młynarska, E.; Franczyk, B.; Rysz, J.
Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease. Int. J. Mol. Sci. 2021, 22, 9995.
https://doi.org/10.3390/ijms22189995
AMA Style
Baran W, Krzemińska J, Szlagor M, Wronka M, Młynarska E, Franczyk B, Rysz J.
Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease. International Journal of Molecular Sciences. 2021; 22(18):9995.
https://doi.org/10.3390/ijms22189995
Chicago/Turabian Style
Baran, Wiktoria, Julia Krzemińska, Magdalena Szlagor, Magdalena Wronka, Ewelina Młynarska, Beata Franczyk, and Jacek Rysz.
2021. "Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease" International Journal of Molecular Sciences 22, no. 18: 9995.
https://doi.org/10.3390/ijms22189995
APA Style
Baran, W., Krzemińska, J., Szlagor, M., Wronka, M., Młynarska, E., Franczyk, B., & Rysz, J.
(2021). Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease. International Journal of Molecular Sciences, 22(18), 9995.
https://doi.org/10.3390/ijms22189995